openPR Logo
Press release

Sulfonamide Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2029

10-15-2020 03:32 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: TMR

Sulfonamide Market - Global Industry Analysis, Size, Share,

Sulfonamide Market: Introduction

Sulfonamide is a functional group used in various drug formulation which is commonly known as sulpha drugs or sulfa drugs. It is among the first antimicrobial drug used in the treatment of bacterial infections in animals and humans. Sulfonamides act as antimetabolites which block purine and pyrimidine biosynthesis during the synthesis of folic acid, thereby inhibiting bacterial infection. Rising awareness on preventing disease, growing demand for functional food and increasing prevalence of the infectious disease worldwide drive the growth of sulfonamide market. Also, an increase in healthcare expenditure and increasing awareness about health-consciousness results in the growth of the global sulfonamide market and is projected to open new opportunities for the sulfonamide market in the coming future. The global market for sulfonamide is estimated to witness a healthy CAGR during the forecast period of 2020 to 2030.

Get Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6541

Sulfonamide Market: Market Dynamics

Increased usage of sulfonamide in treating infectious diseases and the rising popularity of functional food is the key factor augmenting the growth of sulfonamide market globally. Sulfonamide is commonly used in the treatment and prevention of numerous diseases such as bacterial infection, diabetes, HIV AIDS, urinary tract infection, and many more. Thus, an increase in the frequency of chronic disorders worldwide and increasing aging population leads to an increased sulfonamide consumption. Moreover, the ease of availability of various sulfonamide drugs at a reasonable price further contributes to the growth of the global sulfonamides market. Besides, growing R&D activities and government funding in healthcare sector results in the development of innovative and better-quality sulfonamides with enhanced therapeutic activity which further fuels the growth of global sulfonamide market over the forecast period. In addition, rapid development of sulfonamide based dietary supplements is likely to boost the growth of global sulfonamide market. However, side effects associated with sulfonamides such as dizziness, diarrhea, hypersensitivity, kernicterus, and nausea or vomiting and presence of potential substitutes with minor side effects such as macrolides, quinolones are likely to affect the growth of the global sulfonamides market.

Sulfonamide Market: Segmentation

Based on the function, the sulfonamide market is segmented as:

Antimicrobial
Hypoglycemic
Diuretic
Anti-epileptic
Anti-cancer
Anti-protozoal
Anti-inflammatory
Anti-retroviral

Based on the type, the sulfonamide market is segmented as:

Antibiotic
Non-antibiotic

Request TOC of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=6541

Sulfonamide Market: Regional Outlook

Global sulfonamide market is divided into six regions including North America, Latin America, Europe, East Asia, South Asia & Oceania, and Middle East & Africa (MEA). Among the regions mentioned above, sulfonamide is most commonly used in developing countries such as China, India, and ASEAN countries owing to its low prices and ease of availability. China and India with the largest population pool globally have witnessed a high frequency of diseased and infectious people resulting in the growth of sulfonamide consumption. In contrast, the usage of sulfonamide in developed countries has witnessed a downfall due to the seldom appear of sulfonamide in doctor’s prescription and growing awareness about the side effects of sulfonamide. North America is expected to witness steady growth over the forecast period due to growing awareness concerning sulfa drugs, well-developed healthcare infrastructure and presence of harmonized regulatory structure. Europe is likely to witness a similar trend as North America, with moderate growth over the coming years. Latin America is anticipated to grow higher than the global average growth leveraging the low-cost benefits of sulfonamide.

Sulfonamide Market: Market stakeholders

Key market stakeholders in the global sulfonamide market are Boehringer Ingelheim Pharmaceuticals, Abbott Laboratories, GlaxoSmithKline plc, Bayer AG, King Pharmaceuticals, Novartis International AG, Mylan Pharmaceuticals, Teva Pharmaceuticals, Stiefel Laboratories, Roche Holding AG, Sanofi Aventis, Par Pharmaceutical and Pfizer. Bayer AG was the first company to experiment with Prontosil in 1932. The sulfonamide market consists of well-diversified global and regional players with the global vendors ruling the market.

Read Comprehensive Overview of Report @ https://www.tmrresearch.com/sulfonamide-market

The research report presents a comprehensive assessment of the sulfonamide market and contains thoughtful insights, facts, historical data and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The sulfonamide market report provides analysis and information, according to market segments such as geographies, applications and types.

Sulfonamide Market Report Covers Exhaustive Analysis On:

Market Segments
Market Dynamics
Market Size & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

The sulfonamide report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The Sulfonamide report provides an in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The sulfonamide report also maps the qualitative impact of various market factors on market segments and geographies.

Contact:

TMR Research,

3739 Balboa St # 1097,

San Francisco, CA 94121

United States

Tel: +1-415-520-105

About TMR Research:

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sulfonamide Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2029 here

News-ID: 2160947 • Views:

More Releases from TMR

Emerging Opportunities in Logistics Market with Current Trends Analysis
Emerging Opportunities in Logistics Market with Current Trends Analysis
The global Logistics market is estimated to attain a valuation of US$ 15,273.21 Bn by the end of 2027, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 4.5% during the forecast period, 2019-2027. The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of the
Energy Measurement IC Market is expected to reach US$ 8.39 Bn by the end of 2031
According to a Transparency Market Research (TMR) research report, the global energy measurement ic market is likely to expand at a CAGR of 7.4% during the forecast period, 2022 to 2031. This suggests that the market is expected to reach US$ 8.39 Bn by the end of 2031. The study on the energy measurement ic market adopts rigorous and systematic research approaches to understand the growth dynamic of the market. The
STATCOM UPS Market to Register Double Digit Growth Rate of 16% CAGR by 2024
Over the last decade, rising number of industries and utilities are opting for static synchronous compensator or STATCOM UPS instead of static VAR compensator or SVC UPS. Low harmonic emission coupled with high speed of response is accentuating the expansion of India STATCOM UPS market now and in times to come. Playing a crucial role in voltage control and compensation of reactive power, STATCOM UPS is likely to keep its
Thin Wafer Processing and Dicing Equipment Market US$692.5 mn by 2024 - TMR
Transparency Market Research (TMR) estimates that the global thin wafer processing and dicing equipment market has a highly consolidative landscape. Disco Corp. accounted for largest share of 56.4% in 2015 and likely to be dominant in the coming years. This is creating monopoly in the thin wafer processing and dicing equipment market in terms of competitive presence. The other key players such as EV Group, Plasma-Therm LLC, Lam Research Corp,

All 5 Releases


More Releases for Sulfonamide

Sulfonamide Market Projected to Witness a Double-Digit CAGR During 2030
Sulfonamide Market: Introduction Sulfonamide is a functional group used in various drug formulation which is commonly known as sulpha drugs or sulfa drugs. It is among the first antimicrobial drug used in the treatment of bacterial infections in animals and humans. Sulfonamides act as antimetabolites which block purine and pyrimidine biosynthesis during the synthesis of folic acid, thereby inhibiting bacterial infection. Rising awareness on preventing disease, growing demand for functional food
N-tert-butyl-benzothiazole Sulfonamide Market || With Four Main Geographies And …
This research study on "N-tert-butyl-benzothiazole Sulfonamide market" reports offers the comparative assessment of N-tert-butyl-benzothiazole Sulfonamide market and consist of Historical data, Significance, statistical data, size & share, Market Price & Demand, Business overview, Market Analysis By Product and Market Trends by Key Players. This N-tert-butyl-benzothiazole Sulfonamide Market is Segmented in two type on the basis of type of materials and end-users. It has global market covered in all the regions,
Systemic Antibiotic-Sulfonamide Combination Pharmaceuticals Market Research Repo …
Global Systemic Antibiotic-Sulfonamide Combination Pharmaceuticals Market Sulfonamides are a group of drugs that are derived from sulfanilamide, a sulfur containing compound. Sulfonamides are the most commonly used antibiotics around the world and have been in clinical use since 1968. Sulfonamides, also known as anti-metabolites and sulfa drugs act by inhibiting the folic acid synthesis pathway in a bacterial cell. These antibiotics are considered as selective targeted option since human do not
Global Systemic Antibiotic-Sulfonamide Combination Pharmaceuticals Market Trends …
Sulfonamide are antibiotics which clinical use since years. These drugs are bacteriostatic in nature and are utilized in the treatment of acute, infectious and various other bacterial infections. The drivers for the systemic antibiotic sulfonamide marketwhich pushes volume sale of the drug includes the availability of a large number of generics at affordable prices, increasing the prevalence of various infectious diseases and the worldwide rise in elderly population. For the
Global Systemic Antibiotic-Sulfonamide Combination Pharmaceuticals Market Indust …
Sulfonamide are antibiotics which clinical use since years. These drugs are bacteriostatic in nature and are utilized in the treatment of acute, infectious and various other bacterial infections. The drivers for the systemic antibiotic sulfonamide marketwhich pushes volume sale of the drug includes the availability of a large number of generics at affordable prices, increasing the prevalence of various infectious diseases and the worldwide rise in elderly population. For the
Global Systemic Antibiotic-Sulfonamide Pharmaceutical Market Details & Outlook H …
Albany, New York, May 9, 2017: Sulfonamide are antibiotics which clinical use since years. These drugs are bacteriostatic in nature and are utilized in the treatment of acute, infectious and various other bacterial infections. The drivers for the systemic antibiotic sulfonamide market which pushes volume sale of the drug includes the availability of a large number of generics at affordable prices, increasing the prevalence of various infectious diseases and the